123 related articles for article (PubMed ID: 35489437)
1. Overexpression of programmed death ligand 1 in refractory inflammatory bowel disease.
Nguyen J; Finkelman BS; Escobar D; Xue Y; Wolniak K; Pezhouh M
Hum Pathol; 2022 Aug; 126():19-27. PubMed ID: 35489437
[TBL] [Abstract][Full Text] [Related]
2. Expression of Programmed Death-Ligand 1 by Human Colonic CD90
Beswick EJ; Grim C; Singh A; Aguirre JE; Tafoya M; Qiu S; Rogler G; McKee R; Samedi V; Ma TY; Reyes VE; Powell DW; Pinchuk IV
Front Immunol; 2018; 9():1125. PubMed ID: 29910803
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of spatial PD1 and PD-L1 expression in inflammatory bowel disease samples - a pilot study.
Szczepaniak K; Paskal W; Kuśmierczyk Z; Wejman J; Ostrowska J; Tarnowski W; Włodarski P
Pol J Pathol; 2022; 73(1):50-59. PubMed ID: 35848481
[TBL] [Abstract][Full Text] [Related]
4. Over-Expression of Immunosuppressive Molecules, PD-L1 and PD-L2, in Ulcerative Colitis Patients.
Rajabian Z; Kalani F; Taghiloo S; Tehrani M; Rafiei A; Hosseini-Khah Z; Hosseini V; Ajami A
Iran J Immunol; 2019 Mar; 16(1):62-70. PubMed ID: 30864556
[TBL] [Abstract][Full Text] [Related]
5. Apoptosis in the intestinal mucosa of patients with inflammatory bowel disease: evidence of altered expression of FasL and perforin cytotoxic pathways.
Souza HS; Tortori CJ; Castelo-Branco MT; Carvalho AT; Margallo VS; Delgado CF; Dines I; Elia CC
Int J Colorectal Dis; 2005 May; 20(3):277-86. PubMed ID: 15503066
[TBL] [Abstract][Full Text] [Related]
6. Programmed cell death-1 (PD-1) and programmed death-ligand 1 (PD-L1) expression in PD-1 inhibitor-associated colitis and its mimics.
Cassol CA; Owen D; Kendra K; Braga JR; Frankel WL; Arnold CA
Histopathology; 2020 Aug; 77(2):240-249. PubMed ID: 32298485
[TBL] [Abstract][Full Text] [Related]
7. Distribution of mucosal PD-1 expressing T cells in patients with colitis of different etiologies.
Roosenboom B; Horjus Talabur Horje CS; Smids C; Leeuwis JW; van Koolwijk E; Groenen MJM; Wahab PJ; van Lochem EG
Scand J Gastroenterol; 2021 Jun; 56(6):671-679. PubMed ID: 33779456
[TBL] [Abstract][Full Text] [Related]
8. The significance of PD-1/PD-L1 imbalance in ulcerative colitis.
Shi W; Zhang Y; Hao C; Guo X; Yang Q; Du J; Hou Y; Cao G; Li J; Wang H; Fang W
PeerJ; 2023; 11():e15481. PubMed ID: 37273534
[TBL] [Abstract][Full Text] [Related]
9.
Zhou L; Liu D; Xie Y; Yao X; Li Y
Gut Liver; 2019 Mar; 13(4):430-439. PubMed ID: 30600673
[TBL] [Abstract][Full Text] [Related]
10. PD-L1 upregulation is associated with activation of the DNA double-strand break repair pathway in patients with colitic cancer.
Ozawa N; Yokobori T; Osone K; Katayama C; Suga K; Komine C; Shibasaki Y; Shiraishi T; Okada T; Kato R; Ogawa H; Sano A; Sakai M; Sohda M; Ojima H; Miyazaki T; Motegi Y; Ide M; Yao T; Kuwano H; Shirabe K; Saeki H
Sci Rep; 2021 Jun; 11(1):13077. PubMed ID: 34158547
[TBL] [Abstract][Full Text] [Related]
11. Checkpoint Inhibitor Colitis Shows Drug-Specific Differences in Immune Cell Reaction That Overlap With Inflammatory Bowel Disease and Predict Response to Colitis Therapy.
Lo YC; Price C; Blenman K; Patil P; Zhang X; Robert ME
Am J Clin Pathol; 2021 Jul; 156(2):214-228. PubMed ID: 33555016
[TBL] [Abstract][Full Text] [Related]
12. Impairment of Tissue-Resident Mesenchymal Stem Cells in Chronic Ulcerative Colitis and Crohn's Disease.
Grim C; Noble R; Uribe G; Khanipov K; Johnson P; Koltun WA; Watts T; Fofanov Y; Yochum GS; Powell DW; Beswick EJ; Pinchuk IV
J Crohns Colitis; 2021 Aug; 15(8):1362-1375. PubMed ID: 33506258
[TBL] [Abstract][Full Text] [Related]
13. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
Pedersen G
Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
[TBL] [Abstract][Full Text] [Related]
14. Human Intestinal Macrophages Are Involved in the Pathology of Both Ulcerative Colitis and Crohn Disease.
Dharmasiri S; Garrido-Martin EM; Harris RJ; Bateman AC; Collins JE; Cummings JRF; Sanchez-Elsner T
Inflamm Bowel Dis; 2021 Oct; 27(10):1641-1652. PubMed ID: 33570153
[TBL] [Abstract][Full Text] [Related]
15.
Zhou LY; Xie Y; Li Y
World J Gastroenterol; 2022 Jul; 28(26):3164-3176. PubMed ID: 36051332
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of intestinal mucosal mast cells expressing VPAC1 in close proximity to vasoactive intestinal polypeptide in inflammatory bowel disease and murine colitis.
Casado-Bedmar M; Heil SDS; Myrelid P; Söderholm JD; Keita ÅV
Neurogastroenterol Motil; 2019 Mar; 31(3):e13503. PubMed ID: 30407703
[TBL] [Abstract][Full Text] [Related]
17. Specific Norovirus Interaction with Lewis x and Lewis a on Human Intestinal Inflammatory Mucosa during Refractory Inflammatory Bowel Disease.
Tarris G; de Rougemont A; Estienney M; Charkaoui M; Mouillot T; Bonnotte B; Michiels C; Martin L; Belliot G
mSphere; 2021 Jan; 6(1):. PubMed ID: 33441404
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of interleukin 17 in inflammatory bowel disease.
Fujino S; Andoh A; Bamba S; Ogawa A; Hata K; Araki Y; Bamba T; Fujiyama Y
Gut; 2003 Jan; 52(1):65-70. PubMed ID: 12477762
[TBL] [Abstract][Full Text] [Related]
19. Mismatch repair-deficient colorectal cancer: a model of immunogenic and immune cell-rich tumor despite nonsignificant programmed cell death ligand-1 expression in tumor cells.
Le Flahec G; Badic B; Guibourg B; Doucet L; Bail JP; Marcorelles P; Schick U; Uguen A
Hum Pathol; 2018 Feb; 72():135-143. PubMed ID: 29208565
[TBL] [Abstract][Full Text] [Related]
20. Whole genome gene expression meta-analysis of inflammatory bowel disease colon mucosa demonstrates lack of major differences between Crohn's disease and ulcerative colitis.
Granlund Av; Flatberg A; Østvik AE; Drozdov I; Gustafsson BI; Kidd M; Beisvag V; Torp SH; Waldum HL; Martinsen TC; Damås JK; Espevik T; Sandvik AK
PLoS One; 2013; 8(2):e56818. PubMed ID: 23468882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
